Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Novarex Co., Ltd. (194700:KRX), powered by AI.
Novarex Co., Ltd. is currently trading at ₩14,080. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Novarex Co., Ltd. on Alpha Lenz.
Novarex Co., Ltd.'s P/E ratio is 7.3.
“Novarex Co., Ltd. trades at a P/E of 7.3 (undervalued) with solid ROE of 15.0%. 3Y revenue CAGR of 12.8% highlights clear growth momentum.”
Ask for details →Novarex Co., Ltd. is a renowned Korean company primarily engaged in the development and manufacturing of health functional foods and nutraceutical products. As a pivotal player in the nutraceutical industry, its core function is to harness the synergy between biotechnology and nutritional advancements to create innovative health products that cater to a wide array of health conditions and consumer needs. The company offers a diverse portfolio that includes dietary supplements, functional beverages, and vitamins, targeting both domestic and international markets. Novarex Co., Ltd. impacts various sectors including healthcare, wellness, and nutrition by fostering healthier lifestyle choices through scientifically backed solutions. With its production facilities adhering to stringent quality standards, the company positions itself as a leader in the fast-growing wellness industry, driving innovation and setting benchmarks in product efficacy and safety. Through strategic partnerships and a commitment to research and development, Novarex Co., Ltd. plays a significant role in the evolving landscape of functional foods, contributing significantly to the market's expansion and increased consumer interest in preventive health care.
“Novarex Co., Ltd. trades at a P/E of 7.3 (undervalued) with solid ROE of 15.0%. 3Y revenue CAGR of 12.8% highlights clear growth momentum.”
Ask for details →Novarex Co., Ltd. (ticker: 194700) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). It has approximately 436 employees. Market cap is $257.0B.
The current price is ₩14,080 with a P/E ratio of 7.26x and P/B of 1.02x.
ROE is 14.99% and operating margin is 10.65%. Annual revenue is $404.3B.